Key result
Changing an initial Heart Team decision from CABG to PCI yields similar 12-month major cardiovascular events rates.
Why the study?
Heart Team revascularization decisions are sometimes changed by different teams, but the clinical implications of switching an initial recommendation from CABG to PCI are unclear.
Does changing the Heart Team decision from CABG to PCI affect 12-month MACE and mortality in patients with multivessel coronary artery disease?
Cohort (n=1,501)
No
Does changing the Heart Team decision from CABG to PCI affect 12-month MACE and mortality in patients with multivessel coronary artery disease?
Changing the Heart Team decision from CABG to PCI in selected patients with multivessel disease results in similar 12-month clinical outcomes compared to proceeding with CABG.
Answers are grounded in this paper and cite their sources.
May support individualized Heart Team decisions in selected multivessel disease; leaves open need for randomized confirmation of MACE equivalence.
Background/Aim. Decision-making by the Heart Team is an established way of making appropriate decisions regarding the management of patients with coronary artery dis-ease. In clinical practice, it is not infrequent to see changes in decisions made by different Heart Teams. However, clinical implications regarding changes in the Heart Team decisions are not clear. The aim of this study was to determine clinical implications of change in the Heart Team decision in patients in whom surgical myocardial revascularization was advised first but consequently changed to percutaneous coronary intervention (PCI). Methods. We retrospectively analyzed data for 1,501 patients admitted to a single tertiary care high-volume center for coronary artery bypass grafting (CABG). In all patients, decisions were made by the Heart Team prior to admission. Upon admission, decisions were reevaluated by another Heart Team. The decision regarding the mode of revascularization was changed in 73 (4.86%) of patients. Propensity matching was made with patients from the same population who underwent CABG. Patients in both groups were followed for major adverse cardiac events (MACE) and total mortality for 12 months. Results. PCI and CABG groups were balanced with respect to demo-graphic and clinical characteristics. All patients had two- and three vessel disease, with similar incidence of left main stenosis (26% in the PCI group and 30.10% in the CABG group). EuroSCORE II was similar between the groups (2.48 ? 2.38 vs. 2.36 ? 2.92). During the follow-up period, a total of 5 (6.80%) MACE in the PCI group and 12 (5.80%) MACE in the CABG group were observed (log rank 0.096, p = 0.757). A total of 6 (8.20%) patients died in the PCI group, and 15 (7.30%) patients died in the CABG group (log rank 0.067, p = 0.796). Conclusion. Our data indicate that patients in whom CABG was advised first but consequently changed to PCI have a prognosis similar to CABG patients over 12 months after the index procedure.
No takes yet. Share an insight, caveat, or question.
Veljković et al. (2019) conducted a cohort in Coronary artery disease (n=1,501). Change of revascularization decision to PCI vs. CABG was evaluated on Major adverse cardiac events (MACE) (p=0.757). Changing the initial Heart Team decision from CABG to PCI resulted in similar 12-month rates of major adverse cardiac events compared to proceeding with CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: